Skip to content
Research information

GHRP-2 specifications and research profile

Specifications summary

DesignationSynthetic growth-hormone-releasing hexapeptide
Also known asGHRP-2; Pralmorelin; KP-102
Sequence / compositionD-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
Strength10mg × 10 vials
Presentation10-vial case
Purity99%+ HPLC
StorageStore refrigerated at 2-8 C, protected from light.
COABatch document added when available

Description and research context

GHRP-2 is a synthetic hexapeptide and growth-hormone secretagogue receptor ligand. Its defined sequence makes it a reference for comparing peptide secretagogues and endogenous ghrelin-pathway ligands.

Published studies have measured pituitary responses, GHS-R1a dependence and secretory patterns. Observations vary with receptor expression, species and experimental design.

Applications in research

  • GHS-R1a activation assays
  • Pituitary somatotroph response models
  • Secretagogue sequence and potency comparisons

Precautions and interpretation

For controlled laboratory research only. Not for human or veterinary use. The cited findings come from specific biochemical, cellular, structural or preclinical models and must not be treated as usage guidance or evidence of a defined outcome outside those models.

Product information

GHRP-2 research record

Clear product, batch, storage, dispatch and document information for this 10-vial case.

Research context

A synthetic hexapeptide, also known as pralmorelin, studied as a growth-hormone secretagogue receptor ligand in pituitary and receptor-response models.

Product record

The listing identifies the presentation, specification, storage record, dispatch status, and COA availability for the relevant product or batch.

Use restriction

For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.

1 / 1
WhatsApp us